NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,703,005 | -10.9% | 1,927,074 | +16.4% | 1.15% | -1.4% |
Q2 2023 | $26,615,439 | -8.4% | 1,656,219 | -0.8% | 1.16% | -16.5% |
Q1 2023 | $29,062,931 | +49.7% | 1,669,324 | -20.6% | 1.39% | +48.6% |
Q4 2022 | $19,418,479 | +5.4% | 2,101,567 | -1.8% | 0.94% | -1.3% |
Q3 2022 | $18,422,000 | +86.3% | 2,139,579 | +76.3% | 0.95% | +87.0% |
Q2 2022 | $9,889,000 | -25.4% | 1,213,353 | +11.2% | 0.51% | +0.6% |
Q1 2022 | $13,257,000 | -56.1% | 1,091,112 | +23.2% | 0.50% | -54.7% |
Q4 2021 | $30,211,000 | -30.7% | 885,436 | -2.1% | 1.12% | -29.6% |
Q3 2021 | $43,623,000 | +10.7% | 904,298 | +3.7% | 1.58% | +10.4% |
Q2 2021 | $39,389,000 | -30.9% | 872,022 | -26.2% | 1.44% | -30.3% |
Q1 2021 | $57,026,000 | -21.6% | 1,182,382 | -12.5% | 2.06% | -14.7% |
Q4 2020 | $72,727,000 | +44.4% | 1,350,805 | -1.1% | 2.41% | +16.4% |
Q3 2020 | $50,368,000 | +14.0% | 1,365,356 | -4.2% | 2.07% | +7.7% |
Q2 2020 | $44,164,000 | +20.9% | 1,425,555 | +7.7% | 1.92% | -8.9% |
Q1 2020 | $36,536,000 | -16.3% | 1,323,298 | -11.3% | 2.11% | +14.6% |
Q4 2019 | $43,659,000 | +31.4% | 1,492,599 | -14.1% | 1.84% | +18.8% |
Q3 2019 | $33,227,000 | -22.4% | 1,737,819 | -10.9% | 1.55% | -9.7% |
Q2 2019 | $42,806,000 | +11.4% | 1,951,061 | +3.8% | 1.72% | +9.9% |
Q1 2019 | $38,442,000 | +59.7% | 1,878,901 | -1.6% | 1.56% | +32.1% |
Q4 2018 | $24,070,000 | -6.2% | 1,908,795 | +14.2% | 1.18% | +25.6% |
Q3 2018 | $25,663,000 | +42.4% | 1,671,830 | +21.6% | 0.94% | +38.7% |
Q2 2018 | $18,019,000 | +74.5% | 1,374,446 | +8.6% | 0.68% | +64.3% |
Q1 2018 | $10,327,000 | -18.2% | 1,265,547 | -11.1% | 0.41% | -14.8% |
Q4 2017 | $12,619,000 | -17.9% | 1,424,263 | +3.1% | 0.49% | -22.4% |
Q3 2017 | $15,376,000 | +37.5% | 1,381,473 | +10.7% | 0.63% | +34.0% |
Q2 2017 | $11,185,000 | +11.2% | 1,248,371 | -2.1% | 0.47% | +13.1% |
Q1 2017 | $10,059,000 | +20.1% | 1,274,860 | +30.5% | 0.41% | +15.7% |
Q4 2016 | $8,375,000 | +77.7% | 977,256 | +70.5% | 0.36% | +70.0% |
Q3 2016 | $4,712,000 | +95.3% | 573,226 | +91.0% | 0.21% | +81.0% |
Q2 2016 | $2,413,000 | – | 300,160 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |